Aditya Birla Sun Life Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8689 Cr | ₹882 Cr |
Min Investment | ₹5000 | ₹1000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 10 Jul 2019 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 31% |
Expense Ratio | 1.81 | 2.28 |
Manager | Sailesh Raj Bhan | Dhaval Joshi |
ISIN Code | INF204K01968 | INF209KB1N91 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Month | -7.02% | -7.01% |
6 Month | -4.77% | -6.29% |
1 Year | 10.69% | 9.85% |
3 Year | 18.33% | 16.62% |
5 Year | 23.9% | 20.06% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
6 Month | - | - |
1 Year | 9.7% | 7.48% |
3 Year | 26.11% | 25.3% |
5 Year | 21.8% | 19.94% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
1 Year | 18.19% | 29.31% |
3 Year | 20.5% | 15.89% |
5 Year | 20.36% | 24.32% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Standard Deviation | 14.36% | 14.83% |
Sharp | 0.78% | 0.61% |
Beta | 0.87% | 0.96% |
Alpha | 1.67% | 0.67% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Name | Sailesh Raj Bhan | Dhaval Joshi |
Total AUM | ₹96086 Cr | ₹361932 Cr |
Fund Manage | 5 | 55 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 4.4 | 3.49 |
Large Cap | 45.96 | 34.94 |
Mid Cap | 27.12 | 37.39 |
Small Cap | 22.52 | 24.19 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth |
---|---|---|
Others | 4.4 | 3.49 |
Pharmaceuticals & Biotechnology | 75.86 | 77.84 |
Healthcare Services | 17.38 | 16.2 |
Retailing | 2.36 | - |
Chemicals & Petrochemicals | - | 0.79 |
Insurance | - | 1.69 |
Top Comparisons
DSP Banking & PSU Debt Fund - Regular Plan - Growth
3Y Returns6.24%
LIC MF Banking & PSU Debt Fund-Growth
3Y Returns5.96%
Nippon India Growth Fund-Growth Plan-Growth Option
3Y Returns21.1%
Motilal Oswal Midcap Fund-Regular Plan-Growth Option
3Y Returns27.66%
SBI Magnum Gilt Fund - Regular Plan - Growth
3Y Returns7.16%
Baroda BNP Paribas GILT FUND - Regular Plan - Growth Option
3Y Returns6.48%
Edelweiss Recently Listed IPO Fund Regular Plan Growth
3Y Returns8.18%
Quant ESG Equity Fund Regular - Growth
3Y Returns15.87%